Compumedics Limited (AU:CMP) has released an update.
Compumedics Limited has announced a significant boost to their European operations with a $1 million sale of their state-of-the-art Okti neurological wireless amplifier to two leading epilepsy hospitals in Berlin. This new technology has driven a 63% increase in FY24 sales in Europe, solidifying Compumedics’ position in the competitive neurological diagnostic market, which in Europe alone is estimated to be worth up to EUR 300 million with a growth rate of 10% per annum.
For further insights into AU:CMP stock, check out TipRanks’ Stock Analysis page.
